CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products

Por Cruz, Celia N., Tyner, Katherine M., Velazquez, Lydia, Hyams, Kenneth C., Jacobs, Abigail, Shaw, Arthur B., Jiang, Wenlei, Lionberger, Robert, Hinderling, Peter, Kong, Yoon, Brown, Paul C., Ghosh, Tapash, Strasinger, Caroline, Suarez-Sharp, Sandra, Henry, Don, Van Uitert, Maat, Sadrieh, Nakissa, Morefield, Elaine
Publicado em 2013

Summary Report of PQRI Workshop on Nanomaterial in Drug Products: Current Experience and Management of Potential Risks

Por Bartlett, Jeremy A., Brewster, Marcus, Brown, Paul, Cabral-Lilly, Donna, Cruz, Celia N., David, Raymond, Eickhoff, W. Mark, Haubenreisser, Sabine, Jacobs, Abigail, Malinoski, Frank, Morefield, Elaine, Nalubola, Ritu, Prud’homme, Robert K., Sadrieh, Nakissa, Sayes, Christie M., Shahbazian, Hripsime, Subbarao, Nanda, Tamarkin, Lawrence, Tyner, Katherine, Uppoor, Rajendra, Whittaker-Caulk, Margaret, Zamboni, William
Publicado no AAPS J (2014)